Drug Injury Attorney Jeffrey D. DeCarlo Comments on FDA Warning About Benicar Side Effects

The attorney at the Law Offices of Jeffrey D. DeCarlo discusses steps patients who have been harmed by pharmaceutical products can take to protect their rights.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
The FDA issues these warnings only if they believe there are serious health concerns. We strongly recommend that you make an appointment with a doctor as soon as possible if you are experiencing any health problems after taking Benicar.

Miami, FL (PRWEB) December 19, 2013

People who have used Benicar, a popular prescription blood pressure and antihypertension medication, should take a recent warning from the Food and Drug Administration very seriously, Benicar attorney Jeffrey D. DeCarlo said today.

The FDA is warning that olmesartan medoxomil, marketed as Benicar, can cause intestinal problems known as sprue-like enteropathy. The Law Offices of Jeffrey D. DeCarlo, P.A. is prepared to review any potential Benicar lawsuits on behalf of individuals who used the drug for hypertension for at least one year and suffered sprue-like enteropathy, said attorney DeCarlo.

Recent FDA-mandated changes to Benicar (olmesartan medoxomil) tablet warning labels indicate that a small percentage of users may be at risk of suffering painful side effects while taking the drug, including gastrointestinal issues such as sprue-like enteropathy.

“The FDA issues these warnings only if they believe there are serious health concerns,” DeCarlo said. “We strongly recommend that you make an appointment with a doctor as soon as possible if you are experiencing any health problems after taking Benicar. You also should consult with an attorney to learn about your rights.”

DeCarlo said his firm is currently reviewing cases on behalf of Benicar users who suffered an adverse reaction to the drug, including such side effects as intestinal inflammation, sprue-like enteropathy, chronic diarrhea, vomiting, and sudden weight loss.

DeCarlo said the FDA issued the warning in part after a Mayo Clinic study that revealed 22 instances of sprue-like enteropathy, a serious lower intestinal injury which could result in hospitalization or death in patients.

According to the FDA, the drug’s label was updated in July 2013 to reflect these risks, which the FDA said can appear months to years after the drug’s initiation. Internal biopsies on Benicar patients have revealed a condition known as villous atrophy, which is an erosion of the villi in the intestines that help absorb nutrients, according to a statement by the FDA.

DeCarlo said dangerous drug attorneys can help victims hold the pharmaceutical companies accountable. A lawsuit may be necessary to send a message that negligence by drug companies will not be tolerated, he said.

About the Law Offices of Jeffrey D. DeCarlo

Attorney Jeffrey D. DeCarlo is a nationally recognized pharmaceutical injury lawyer who has protected the rights of injury victims for over 15 years. His office is in Miami, Fla., but he serves clients throughout the United States. Attorney Jeffrey DeCarlo is a member of both the Million Dollar Advocates Forum and Multi-Million Dollar Advocates Forum, reserved for a small percentage of attorneys who have secured multi-million dollar verdicts and settlements. In addition to handling dangerous drug claims, attorney Jeffery DeCarlo also handles cases involving defective medical devices, medical malpractice, car accidents, and a variety of personal injury cases.

If you or a loved one was injured by Benicar or any other drug, call 877-572-0065 today for a free case consultation. Visit http://www.decarlolaw.com.

The Law Offices of Jeffrey D. DeCarlo, P.A. is located at:
4500 Biscayne Boulevard, Suite 201
Miami, FL 33137


Contact